Lument Finance Trust Regains NYSE Compliance with Stock Price
Lument Finance Trust, Inc. has regained compliance with NYSE's minimum share price requirement, allowing its stock to continue trading.
Entergy Texas names David C. Borde as new CEO, Chairman
Entergy Texas, Inc. appoints David C. Borde as CEO and Chairman, effective immediately, following the resignation of Eliecer Viamontes.
Moleculin Biotech unveils corporate presentation update
Moleculin Biotech, Inc. releases a corporate presentation to enhance transparency and engage with stakeholders in the pharmaceutical preparations sector.
Vaxcyte reports positive Phase 3 trial results for VAX-31
Vaxcyte, Inc. announces positive topline data from its Phase 3 OPUS-1 trial for VAX-31, a new pneumococcal conjugate vaccine candidate.
New Fortress Energy's Fast LNG Unit Offline Due to Turbine Issue
New Fortress Energy Inc. reports its Fast LNG unit is offline due to a mechanical issue, with expectations to resume operations in Q4 2026.
Cadrenal Therapeutics Initiates Strategic Review Process
Cadrenal Therapeutics is exploring strategic opportunities to maximize its asset portfolio, signaling potential changes in the pharmaceutical preparations sector.
Presidio Property Trust announces exchange offer results
Presidio Property Trust, Inc. reveals results of its exchange offer for preferred stock, reflecting strategic financial adjustments in the real estate sector.
Verra Mobility announces new CEO, details Keyser's exit
Verra Mobility Corp reveals Jon Newhard as new CEO, effective November 1, 2026, as Jon Keyser steps down from interim role with a detailed separation agreement.
Ultragenyx settles patent litigation with Navinta over DOJOLVI
Ultragenyx Pharmaceutical Inc. settles patent litigation with Navinta LLC, allowing for the marketing of a generic DOJOLVI starting in 2033.
Five Star Bancorp Declares Quarterly Cash Dividend of $0.25
Five Star Bancorp announces a quarterly cash dividend of $0.25 per share, payable on November 9, 2026, enhancing shareholder value.
NRC Health appoints Trent Green as interim CFO
NRC Health has named Trent Green as interim principal financial officer while he continues as CEO, signaling leadership continuity in the healthcare sector.
Veradermics Reports Positive Phase 3 Trial Results for VDPHL01
Veradermics, Inc. announced positive Phase 3 trial results for VDPHL01, a treatment for hair loss, potentially reshaping the pharmaceutical market.
BioCardia Announces FDA Acceptance of Helix Catheter Submission
BioCardia, Inc. announces FDA acceptance of its Helix catheter pre-submission package, signaling potential growth in the biological products market.
ArriVent BioPharma Announces Phase 1b Results for Firmonertinib
ArriVent BioPharma reveals promising Phase 1b results for firmonertinib, targeting EGFR PACC-mutant non-small cell lung cancer.
MKS Inc. sells Ophir Optics business to TTM Technologies for $650M
MKS Inc. has entered a definitive agreement to sell its Ophir Optics business to TTM Technologies for $650 million, expected to close in Q2 2027.
Expand Energy Corp appoints Daniel E. Brown as CEO
Expand Energy Corp has appointed Daniel E. Brown as CEO, effective October 26, 2026, aiming to enhance its strategic direction in the energy sector.
CorMedix Announces FDA Acceptance for REZZAYO sNDA
CorMedix Inc. announces FDA acceptance of its sNDA for REZZAYO, targeting invasive fungal diseases, with promotional efforts planned for late 2027.
Disc Medicine reports successful Phase 3 trial results for bitopertin
Disc Medicine, Inc. announces successful Phase 3 trial results for bitopertin in treating erythropoietic protoporphyria, paving the way for a potential NDA.
Sculptor Diversified Real Estate Income Trust Announces NAV
Sculptor Diversified Real Estate Income Trust, Inc. reports its net asset value per share for September 30, 2026, providing key insights into its financial performance.
Franklin BSP Real Estate Debt Announces Cash Distributions
Franklin BSP Real Estate Debt, Inc. has announced cash distributions for its common stock, reflecting its commitment to shareholder value.